BIOCRYST PHARMACEUTICALS INC

BCRXReported to SECin USCIK 0000882796Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5
Form 4 lines at BIOCRYST PHARMACEUTICALS INC, most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Stonehouse Jon P—Award$6,247644 sharesSep 2, 2026Stonehouse Jon P$6,247Award · Sep 2Award644Sep 2, 2026
Milne Jill C.—Award$12,4941,288 sharesSep 2, 2026Milne Jill C.$12,494Award · Sep 2Award1,288Sep 2, 2026
MILANO VINCENT—Award$11,2421,159 sharesSep 2, 2026MILANO VINCENT$11,242Award · Sep 2Award1,159Sep 2, 2026
McKee Amy E—Award$6,247644 sharesSep 2, 2026McKee Amy E$6,247Award · Sep 2Award644Sep 2, 2026
Frank Steven—Award$12,4941,288 sharesSep 2, 2026Frank Steven$12,494Award · Sep 2Award1,288Sep 2, 2026